New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

ARKGvsPBEETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.05%
Full ARKG fund page
VS
ETF 2
PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of
BioTech & Genomics
-0.05%
Full PBE fund page

ARK Genomic Revolution ETF (ARKG) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PBE's top sector exposures are Health Care  ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.58% for PBE. ARKG is down -5.11% year-to-date (YTD) with -$10M in YTD flows. PBE performs worse with -7.12% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of ARKG and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs PBE performance and flow charts

Performance

-6.0-4.0-2.00.02.04.06.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

-60 M-40 M-20 M0 M20 M40 M60 M80 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
PBE
-3.62%-6.52%
-10.23%-5.52%
-5.11%-7.12%
+23.23%+19.22%
-2.84%+26.51%
-70.08%+1.84%
Flows
ARKG
PBE
-$50M-$3M
-$85M+$969K
-$10M+$135K
-$210M-$32M
-$627M-$56M
-$2.79B-$39M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
PBE
+39.15%+18.95%
+44.62%+22.28%
+42.26%+20.18%
+45.19%+22.77%
Max drawdown
ARKG
PBE
-19.50%-11.05%
-23.94%-16.18%
-51.98%-22.21%
-80.33%-34.74%
Max drawdown duration
ARKG
PBE
48d65d
77d107d
966d324d
1822d1540d
Trading data

Create an account to view trading data

Join for free
ARKG
PBE
Last sale
3/13/2026 at 1:30 PM
$26.36
$76.18
Previous close
03/12/2026
$26.17
$76.18
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
PBE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
ARKG
PBE
Last price
$26.36
$76.18
1D performance
+0.73%
+0.00%
AuM$1.11 B$240.98 M
E/R0.75%0.58%
Characteristics
ARKG
PBE
Management strategyActivePassive
ProviderArk InvestmentInvesco
Benchmark-Dynamic Biotech & Genome Intellidex Index
N° of holdings3030
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019June 23, 2005
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
73.95%
Switzerland
8.01%
Other
18.04%
PBE
USA
94.25%
Other
5.75%

Sectors

ARKG
Health Care
80.46%
Other
19.54%
PBE
Health Care
96.95%
Other
3.05%
Advertisement

Diversification

ARKG

Total weight of top 15 holdings out of 15

63.79%
PBE

Total weight of top 15 holdings out of 15

61.48%

Top 15 holdings

Data as of January 31, 2026
ARKG
CRISPR THERAPEUTICS
8.01%
PERSONALIS INC
6.15%
GUARDANT HEALTH INC
6.00%
10X GENOMICS INC
5.23%
BEAM THERAPEUTICS
4.81%
ILLUMINA
4.53%
NATERA
4.31%
RECURSION PHARMACEUTICALS
4.01%
CAREDX INC/D
3.44%
VERACYTE INC/D
3.29%
ADAPTIVE BIOTECHNOLOGIES
3.13%
INTELLIA THERAPEUTICS INC
3.10%
ABSCI
2.83%
IONIS PHARMACEUTICALS INC
2.62%
SCHRODINGER
2.33%
PBE
ILLUMINA
5.91%
GILEAD SCIENCES
5.35%
AMGEN-T
5.09%
REGENERON PHARMACEUTICALS
4.87%
UTD THERAPEUT
4.83%
BIOGEN INC
4.76%
INCYTE
4.70%
ALNYLAM PHARMACEUTICALS
4.05%
AMICUS THERAPEUTICS
3.83%
DYNAVAX TECHNOLOGIES
3.60%
NL0015002SN0
3.05%
ACADIA PHARMACEUTICALS
2.98%
MANNKIND
2.89%
BIO-TECHNE CORP
2.83%
EXELIXIS
2.74%
Frequently asked questions about ARKG and PBE

How have the ARKG and PBE ETFs performed in 2026?

As of March 11, 2026, ARKG is down -5.11% year-to-date (YTD), while PBE has lost -7.12%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PBE?

Year-to-date, the ARKG ETF saw -$10M in flows, compared to +$135K for PBE.

Which ETF is more volatile: ARKG or PBE?

Over the past year, ARKG had a volatility of 44.62%, while PBE experienced 22.28%.

Which ETF is bigger: ARKG or PBE?

As of March 11, 2026, ARKG holds $1.11 B in assets under management (AUM), while PBE manages $240.98 M.

What sectors do the ARKG and PBE ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.

What are the top holdings of the ARKG ETF and PBE ETF?

ARKG top holdings include CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC. PBE holds in its top three: ILLUMINA, GILEAD SCIENCES and AMGEN-T.

Which ETF is more diversified: ARKG or PBE?

ARKG holds 30 securities with 63.79% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.48%.

Advertisement
Latest news about ARKG & PBE
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast